Respiratory Medicine
The sponsor is involved in clinical research on chronic obstructive pulmonary disease, with attention to lung function, long-term respiratory decline, and treatment-related outcomes in adults living with chronic airway disease.
- COPD
- FEV1
- Long-term pulmonary function
Its respiratory research activity includes interest in interventions aimed at preserving airflow and assessing changes in pulmonary performance over extended follow-up.
Immune-Mediated Complications
The sponsor also focuses on acute graft-versus-host disease in patients who are steroid-refractory or unable to receive ruxolitinib, reflecting interest in severe post-transplant immune complications.
- Acute GVHD
- Steroid-refractory disease
- Ruxolitinib-intolerant patients
This area centers on difficult-to-treat inflammatory and immune dysregulation after transplantation.
Cell-Based Therapies
Clinical research funded by the sponsor includes investigation of mesenchymal stromal cells derived from adipose tissue, with a therapeutic emphasis on regenerative and immunomodulatory applications.
- Mesenchymal stromal cells
- Allogeneic cell therapy
- Adipose tissue-derived cells
The sponsor’s portfolio shows interest in advanced cellular approaches for immune-related disorders.
Immunomodulation and Targeted Cell Engineering
Another therapeutic domain is the use of genetically modified cells designed to express CXCR4 and IL-10, indicating a focus on immune regulation and cell trafficking in inflammatory disease settings.
- CXCR4
- IL-10
- Genetically engineered cellular products
This research interest aligns with treatment strategies for complex transplant-associated immune injury.
